MDS Diagnostic Services Completes Sale of Interest in Calgary Laboratory Services Partnership
04 Aprile 2006 - 3:00PM
PR Newswire (US)
TORONTO, April 4 /PRNewswire-FirstCall/ -- MDS Diagnostic Services,
a leading provider of laboratory testing and management services in
Canada and a subsidiary of MDS Inc. (TSX: MDS; NYSE: MDZ),
announced the sale of its interest in the Calgary Laboratory
Services partnership to the Calgary Health Region, effective April
3, 2006. Under the terms of the agreement, the Calgary Health
Region purchased MDS's 25% interest in Calgary Laboratory Services
for $21.4 million. The business, which was moved into discontinued
operations during the fourth quarter of 2005, generated
approximately $70 million in revenues and $1.5 million in net
income in 2005. MDS Inc. will record this sale in the second
quarter ending April 30, 2006. MDS Diagnostic Services, a business
unit of MDS Inc., is a leading provider of laboratory testing and
management services. MDS Inc. is a global life sciences company
that provides market-leading products and services that our
customers need for the development of drugs and diagnosis and
treatment of disease. We are a leading global provider of
pharmaceutical contract research, medical isotopes for molecular
imaging, radiotherapeutics, and analytical instruments. MDS has
more than 8,800 highly skilled people in 28 countries. Find out
more at http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24
hours a day. This document contains forward-looking statements.
Some forward-looking statements may be identified by words like
"expects", "anticipates", "plans", "intends", "indicates" or
similar expressions. The statements are not a guarantee of future
performance and are inherently subject to risks and uncertainties.
The Company's actual results could differ materially from those
currently anticipated due to a number of factors, including, but
not limited to, successful integration of structural changes,
including restructuring plans, acquisitions, technical or
manufacturing or distribution issues, the competitive environment
for the Company's products, the degree of market penetration of the
Company's products, and other factors set forth in reports and
other documents filed by the Company with Canadian and US
securities regulatory authorities from time to time. DATASOURCE:
MDS Inc. CONTACT: Investor Contact: Sharon Mathers, Vice-President,
Investor Relations, (416) 675-6777 ext. 2695, ; Media Contact: Norm
Berberich, Senior Manager, Communications, (416) 675-6777 ext.
2800,
Copyright